What Insurances Cover Wegovy
It is an extremolyte , a small stress-protection molecule that protects microorganisms living under extreme conditions such as salt lakes, hot springs, arctic ice, the deep sea, or deserts
To date, the FDA has approved only liraglutide and semaglutide for weight loss in the pediatric population
The first GLP-1 receptor agonist was approved for diabetes treatment in 2005
For a broader view of candidates advancing through late-stage development, our GLP-1 drug pipeline 2026 tracker covers the full field of emerging oral and injectable agents, including AstraZeneca and Eccogenes elecoglipron, for which Phase 3 trials were announced in January 2026, and Structure Therapeutics aleniglipron, which is advancing through Phase 2 with a Phase 3 programme expected to begin in the second half of 2026
Typical frequency: 1 to 3 injections per day, often at bedtime to amplify the natural nocturnal GH pulse